🇺🇸 Polio Sabin in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 11

Most-reported reactions

1. Gastroenteritis — 2 reports (18.18%)
2. Dehydration — 1 report (9.09%)
3. Eye Pruritus — 1 report (9.09%)
4. Immune Reconstitution Inflammatory Syndrome — 1 report (9.09%)
5. Immune Reconstitution Syndrome — 1 report (9.09%)
6. Malaria — 1 report (9.09%)
7. Pneumonia — 1 report (9.09%)
8. Pseudomembranous Colitis — 1 report (9.09%)
9. Tachypnoea — 1 report (9.09%)
10. Upper Respiratory Tract Infection — 1 report (9.09%)

Source database →

Frequently asked questions

Is Polio Sabin approved in United States?

Polio Sabin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Polio Sabin in United States?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.